| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
| 12/12/2001 | EP0783586B1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 12/12/2001 | EP0733712B1 Process for producing substance |
| 12/12/2001 | EP0662946B2 Unsaturated aliphatic dicarboxylic acids |
| 12/12/2001 | EP0651808B1 Recombinant dna encoding a desulfurization biocatalyst |
| 12/12/2001 | EP0522159B1 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap |
| 12/12/2001 | CN1326512A Process for the production of hydrogen sulphide from elemental sulphur and use thereof in heavy metal recovery |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326466A Method of producing functional immunoglubulin superfaminly protein |
| 12/12/2001 | CN1325959A Genes from genome |
| 12/12/2001 | CN1076052C Nucleic acid sequences, carrier containing them, medical compositions and usage for treatment |
| 12/11/2001 | US6329571 Transforming immature embryo cells of indica rice by agrobacterium tumefaciens and selecting transformed cells by using a drug for selection |
| 12/11/2001 | US6329568 Tospovirus resistance in plants |
| 12/11/2001 | US6329566 Methods for the detection, treatment, and prevention of neurodegeneration |
| 12/11/2001 | US6329517 Dermatomyositis-specific auto-antigen |
| 12/11/2001 | US6329202 Antibodies directed against binding associated epitopes |
| 12/11/2001 | US6329198 Production and use of human nm23 protein and antibodies therefor |
| 12/11/2001 | US6329190 Targetting adenovirus with use of constrained peptide motifs |
| 12/11/2001 | US6329189 Enzyme producing tartaric acid ether compound and process for producing tartaric acid ether compounds using this enzyme |
| 12/11/2001 | US6329187 Endoglucanases |
| 12/11/2001 | US6329185 A polypeptide from a basidiomycota fungus; for preparing mono-component galactanase composition; for use as bulking agents, preparation of fruit or vegetable juices, regulate consistency and appearance of processed fruits or vegetables |
| 12/11/2001 | US6329183 Providing diols which can be converted into 3-hydroxypropionate or 3-hydroxyvalerate monomers by enzymes expressed by organisms; culturing organisms to produce polyhydroxyalkanoates |
| 12/11/2001 | US6329176 Culturing mammals cells containing a nucleic acid sequence that codes a saccharomyces endoprotease, in a serum free medium and isolating the protein from the medium |
| 12/11/2001 | US6329141 Genetically engineered dna that when transformed in phaffia rhodozyme is highly expressed in the glycolytic pathway coding for glyceraldehye-3-phosphate dehydrogenase or a ribosomal protein encoding gene |
| 12/11/2001 | US6329138 Method for detection of the antibiotic resistance spectrum of mycobacterium species |
| 12/11/2001 | US6328970 Rapamycin position 27 conjugates |
| 12/11/2001 | US6328968 Organ transplant |
| 12/11/2001 | US6328964 Method to treat multiple sclerosis with GP39-specific antibodies |
| 12/11/2001 | US6328963 For purifying or assaying human mp52 produced b genetic engineering techniques |
| 12/11/2001 | US6328958 Deleted adenovirus vectors and methods of making and administering the same |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2281956C A novel protease |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/11/2001 | CA2090614C 5' to 3' exonuclease mutations of thermostable dna polymerases |
| 12/11/2001 | CA2065874C Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 12/11/2001 | CA2050477C T cell growth factor |
| 12/11/2001 | CA2022487C Optimized fermentation processes for the preparation of foreign proteins in e.coli |
| 12/06/2001 | WO2001092533A1 Anti-listeria bacteriocin |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092501A1 Improved nucleic acid modifying enzymes |
| 12/06/2001 | WO2001023607A3 Multiplex pcr for detecting ehec infections |
| 12/06/2001 | WO2001016345A3 Sequence-specific dna recombination in eukaryotic cells |
| 12/06/2001 | WO2001011075A3 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | WO2000038517A9 Methods for reducing adverse side effects associated with cellular transplantation |
| 12/06/2001 | WO2000011036A9 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 12/06/2001 | US20010049830 Molecular farming |
| 12/06/2001 | US20010049137 DNA fragments derived from the genomic DNA of HPV-33, including recombinant vectors, which cells are replicated in host cells and expressed as immunogenic proteins; diagnosis of tumors; antibodies to detect viral infections |
| 12/06/2001 | US20010049129 Containing a recombinant plasmid pVIC40 and deposited on Nov. 19, 1987 in the collection of microorganism cultures at the USSR Antibiotics Rearch Institute under Reg. No. 1867; efficiency; nutrients; feeds; drugs |
| 12/06/2001 | US20010049128 Cultivating a microorganism which produces and excretes an L-amino acid, by adding to the broth L-proline or an L-proline derivative as an osmoprotective agent to suppress the effects on the cells of the hyperosmotic stress |
| 12/06/2001 | US20010049126 Escherichia constructed from a sucrose non-assimilative strain, harboring sucrose-6-phosphotransferase system (sucrose PTS) genes that can produce an amino acid other than threonine; using sucrose as carbon source improves yield |
| 12/06/2001 | US20010049124 Fermentation using as microorganism a polysaccharide negative yeast strain Moniliella, concentrating the unrefined micro-organism-free fermentation culture medium to dry substance, crystallizing; purity, simplification |
| 12/06/2001 | US20010049123 Nucleotide sequences encoding the dapC gene and process for the production of L-lysine |
| 12/06/2001 | US20010048928 Herpesvirus particles comprising fusion protein and their preparation and use |
| 12/06/2001 | US20010048917 Skin equivalent and methods of forming and using same |
| 12/06/2001 | CA2409417A1 Improved nucleic acid modifying enzymes |
| 12/05/2001 | EP1160901A2 Process for generating electrical power using a fuel cell |
| 12/05/2001 | EP1160334A2 Probe for diagnosing infectious disease arising from Pseudomonas aeruginosa |
| 12/05/2001 | EP1160331A1 Enzymatic oxidations |
| 12/05/2001 | EP1160330A1 Substances wk-5344a and wk-5344b and process for producing the same |
| 12/05/2001 | EP1160327A2 Novel proteolytic enzymes and their use in detergents |
| 12/05/2001 | EP1160325A1 Avermectin aglycon synthase genes |
| 12/05/2001 | EP1160322A2 Human melanocyte stimulating hormone receptors |
| 12/05/2001 | EP1160256A2 Monoclonal antibody specific for beta-A4 peptide |
| 12/05/2001 | EP1159295A1 Method of purifying whey of lactic acid fermentation by electrodialysis |
| 12/05/2001 | EP1159286A1 Tumor necrosis factor receptors 6 alpha and 6 beta |
| 12/05/2001 | EP1158993A1 Bacterial membrane fractions with adjuvant effect |
| 12/05/2001 | EP0951563A4 A new eia test using non-dentured hiv antigen for early detection of hiv infection |
| 12/05/2001 | EP0824595B1 Process for making 1,3-propanediol from carbohydrates using mixed microbial cultures |
| 12/05/2001 | EP0805856B1 Animal feed additives comprising xylanase |
| 12/05/2001 | EP0663953B1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 12/05/2001 | EP0651809B1 A family of map2 protein kinases |
| 12/05/2001 | CN1325453A Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 12/05/2001 | CN1325450A Adenovirus-mediated gene therapy |
| 12/05/2001 | CN1325444A Construction of production strains for producing substituted phenols by specifically inactivating genes of the eugenol and ferulic acid catabolism |
| 12/05/2001 | CN1325443A Glycosylated proteins having reduced allergenicity |
| 12/05/2001 | CN1325442A Endothelial cell proliferation inhibitors derived from human prothrombin |
| 12/05/2001 | CN1325271A Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 12/05/2001 | CN1324954A Method for detecting flu A-type and B-type in clinic sample |
| 12/05/2001 | CN1324882A Purified PH-neutral rhizoctonia laccase and nucleic acid for coding said laccase |
| 12/05/2001 | CN1075836C Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 12/04/2001 | US6326477 Nucleotide sequences coding polypeptide which maintains viability in genetically engineeered fungus; for use as a tool in controlled gene expression |
| 12/04/2001 | US6326464 Genetically engineered tumor suppressor protein; for use in the treatment of cancers; antiproliferative agents |
| 12/04/2001 | US6326462 Polypeptides exhibits lumazine synthase |
| 12/04/2001 | US6326356 Antitumor agents |
| 12/04/2001 | US6326351 Insecticides |
| 12/04/2001 | US6326350 Genetic engineering |
| 12/04/2001 | US6326195 Recombinant retroviral vector |
| 12/04/2001 | US6326177 Starting apoptosis in target cells; apply electric pulse to target cells, monitor cells for apoptosis |
| 12/04/2001 | US6326170 Prokaryotic polynucleotides, polypeptides and their uses |
| 12/04/2001 | US6326159 Receptors for immune complexes |
| 12/04/2001 | US6326016 Plant immunization compositions |
| 12/04/2001 | US6326008 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 12/04/2001 | US6326001 Recombinant vaccine for diseases caused by encapsulated organisms |
| 12/04/2001 | US6325999 Use of Fas ligand to suppress T-lymphocyte-mediated immune responses |
| 12/04/2001 | CA2238668C Novel enzyme catalyzing dephosphorylation |